CBD Life Sciences, Inc. (CBDL)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
CBD Life Sciences Shareholders Equity (Quarterly) : 0.5581M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5581M |
| March 31, 2026 | 0.7401M |
| December 31, 2025 | 0.7667M |
| September 30, 2025 | 0.5425M |
| June 30, 2025 | 0.5015M |
| March 31, 2025 | 0.436M |
| December 31, 2024 | 0.3926M |
| September 30, 2024 | 0.3617M |
| June 30, 2024 | 0.3247M |
| March 31, 2024 | 0.3422M |
| December 31, 2023 | 0.3946M |
| September 30, 2023 | 0.3939M |
| June 30, 2023 | 0.4026M |
| March 31, 2023 | 0.4496M |
| December 31, 2022 | 0.4732M |
| September 30, 2022 | 0.5519M |
| June 30, 2022 | 0.7659M |
| March 31, 2022 | 0.9692M |
| December 31, 2021 | 1.333M |
| September 30, 2021 | 1.471M |
| June 30, 2021 | 0.6548M |
| March 31, 2021 | 0.2231M |
| December 31, 2020 | -0.0204M |
| September 30, 2020 | -0.0123M |
| June 30, 2020 | 1.238M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9969M |
| December 31, 2019 | 1.031M |
| September 30, 2019 | 0.9203M |
| June 30, 2019 | 1.026M |
| March 31, 2019 | 1.127M |
| December 31, 2018 | 0.0247M |
| September 30, 2018 | 2.715M |
| June 30, 2018 | 2.495M |
| March 31, 2018 | 2.436M |
| December 31, 2017 | 2.375M |
| September 30, 2017 | -0.0107M |
| June 30, 2017 | 0.5834M |
| March 31, 2017 | 0.5113M |
| December 31, 2016 | 0.1282M |
| September 30, 2016 | 0.1221M |
| June 30, 2016 | 0.1413M |
| March 31, 2016 | 0.1669M |
| December 31, 2015 | 0.1867M |
| September 30, 2015 | 0.2093M |
| June 30, 2015 | 0.231M |
| March 31, 2015 | 0.2608M |
| December 31, 2014 | -0.0134M |
| September 30, 2014 | -0.1663M |
| June 30, 2014 | 0.1622M |
| March 31, 2014 | 0.3569M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ashland, Inc. | 1.87B |
| Achieve Life Sciences, Inc. | -14.68M |
| BioAdaptives, Inc. | -1.760M |
| BellRing Brands, Inc. | -467.20M |
| Aspire-Lakewood Holdings, Inc. | 11.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.5179M |
| Total Liabilities (Quarterly) | -0.0402M |
| Debt to Equity Ratio | -0.0122 |
| Current Ratio | -15.43 |
| Net Debt Paydown Yield | 0.07% |